Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZocuShield is a **topical eyelid gel** developed by **Zocular** for eyelid hygiene and management of **dry eye disease, meibomian gland dysfunction, blepharitis, and eyelid margin disease**. It is best characterized as a **non-pharmaceutical ocular surface care product** rather than a conventional drug, and it incorporates **Zokrex**, a patented **okra-derived polysaccharide system**, together with botanical ingredients such as aloe, caffeine, raspberry seed oil, and other natural extracts. Its intended mechanism is primarily **physical cleansing and biofilm disruption/penetration at the eyelid margin**, helping remove debris and hydrate periocular tissues rather than acting through a defined receptor, enzyme, or other molecular pharmacology target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ZocuShield.